Literature DB >> 29129298

Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis.

Ekaterina Safroneeva1, Alex Straumann2, Alain M Schoepfer3.   

Abstract

Patients with eosinophilic esophagitis (EoE) present with symptoms accompanied by behavioral adaptions to living with this condition. These include swallowing- and nonswallowing-associated pain in adulthood. In children, EoE symptoms vary with age and include vomiting, abdominal pain, and dysphagia. Studies using validated patient-reported outcome measures have demonstrated that symptoms in EoE are associated with severe biologic alterations and that patients on the low biologic severity spectrum have few symptoms. This nonlinear nature of the relationship between symptoms and biologic findings has important implications for among other things the length of diagnostic delay, selection of patients for clinical trials, trial duration, and long-term management of EoE patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eosinophilic esophagitis; Patient-reported outcomes; Quality of life; Regulatory authorities; Symptoms

Mesh:

Year:  2018        PMID: 29129298      PMCID: PMC8237235          DOI: 10.1016/j.giec.2017.08.001

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  33 in total

Review 1.  Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Authors:  Alfredo J Lucendo; Javier Molina-Infante; Ángel Arias; Ulrike von Arnim; Albert J Bredenoord; Christian Bussmann; Jorge Amil Dias; Mogens Bove; Jesús González-Cervera; Helen Larsson; Stephan Miehlke; Alexandra Papadopoulou; Joaquín Rodríguez-Sánchez; Alberto Ravelli; Jukka Ronkainen; Cecilio Santander; Alain M Schoepfer; Martin A Storr; Ingrid Terreehorst; Alex Straumann; Stephen E Attwood
Journal:  United European Gastroenterol J       Date:  2017-01-23       Impact factor: 4.623

2.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.

Authors:  Alain M Schoepfer; Ekaterina Safroneeva; Christian Bussmann; Tanja Kuchen; Susanne Portmann; Hans-Uwe Simon; Alex Straumann
Journal:  Gastroenterology       Date:  2013-08-13       Impact factor: 22.682

3.  The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life.

Authors:  T H Taft; E Kern; M A Kwiatek; I Hirano; N Gonsalves; L Keefer
Journal:  Aliment Pharmacol Ther       Date:  2011-08-02       Impact factor: 8.171

4.  Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.

Authors:  Stephan R Vavricka; Sabrina M Spigaglia; Gerhard Rogler; Valérie Pittet; Pierre Michetti; Christian Felley; Christian Mottet; Christian P Braegger; Daniela Rogler; Alex Straumann; Peter Bauerfeind; Michael Fried; Alain M Schoepfer
Journal:  Inflamm Bowel Dis       Date:  2011-04-20       Impact factor: 5.325

5.  Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis.

Authors:  Joan W Chen; John E Pandolfino; Zhiyue Lin; Jody D Ciolino; Nirmala Gonsalves; Peter J Kahrilas; Ikuo Hirano
Journal:  Endoscopy       Date:  2016-05-20       Impact factor: 10.093

6.  Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study.

Authors:  B Giriens; P Yan; E Safroneeva; M Zwahlen; A Reinhard; A Nydegger; S Vavricka; C Sempoux; A Straumann; A M Schoepfer
Journal:  Allergy       Date:  2015-09-13       Impact factor: 13.146

7.  Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.

Authors:  Laurent Peyrin-Biroulet; Walter Reinisch; Jean-Frederic Colombel; Gerassimos J Mantzaris; Asher Kornbluth; Robert Diamond; Paul Rutgeerts; Linda K Tang; Freddy J Cornillie; William J Sandborn
Journal:  Gut       Date:  2013-08-23       Impact factor: 23.059

8.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

9.  A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.

Authors:  Stephan Miehlke; Petr Hruz; Michael Vieth; Christian Bussmann; Ulrike von Arnim; Monther Bajbouj; Christoph Schlag; Ahmed Madisch; Christiane Fibbe; Henning Wittenburg; Hans Dieter Allescher; Max Reinshagen; Stefan Schubert; Jan Tack; Michaela Müller; Patrick Krummenerl; Joris Arts; Ralph Mueller; Karin Dilger; Roland Greinwald; Alex Straumann
Journal:  Gut       Date:  2015-03-19       Impact factor: 23.059

10.  Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

Authors:  Jan Sørensen; Merete Lund Hetland
Journal:  Ann Rheum Dis       Date:  2014-02-17       Impact factor: 19.103

View more
  5 in total

Review 1.  A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Sandeep K Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-30       Impact factor: 11.382

Review 2.  Anxiety and Depression in Eosinophilic Esophagitis: A Scoping Review and Recommendations for Future Research.

Authors:  Tiffany H Taft; Livia Guadagnoli; Emily Edlynn
Journal:  J Asthma Allergy       Date:  2019-12-09

Review 3.  Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach.

Authors:  Pierfrancesco Visaggi; Lucia Mariani; Veronica Pardi; Emma Maria Rosi; Camilla Pugno; Massimo Bellini; Fabiana Zingone; Matteo Ghisa; Elisa Marabotto; Edoardo G Giannini; Vincenzo Savarino; Santino Marchi; Edoardo V Savarino; Nicola de Bortoli
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

4.  Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis.

Authors:  Tiffany H Taft; Dustin A Carlson; Madison Simons; Sonia Zavala; Ikuo Hirano; Nirmala Gonsalves; John E Pandolfino
Journal:  Gastroenterology       Date:  2021-06-19       Impact factor: 33.883

Review 5.  Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.

Authors:  Simon Nennstiel; Christoph Schlag
Journal:  World J Gastroenterol       Date:  2020-09-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.